Del. Judge Clears Liquidia To Sell Lung-Disease Drug
A Delaware federal judge has ruled that biochemical startup Liquidia can launch its lung disease drug after the Federal Circuit upheld a patent board ruling cutting out the remaining claims in...To view the full article, register now.
Already a subscriber? Click here to view full article